Brainomix
Series C in 2025
Brainomix develops AI-powered imaging biomarkers for neurological and cerebrovascular disorders. Its software suite, including e-ASPECTS, e-CTA, and e-Mismatch, automates brain scan analysis to assist physicians in making timely treatment decisions for stroke patients.
DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.
PhoreMost
Series B in 2024
PhoreMost is a UK-based drug discovery company specializing in identifying new druggable targets for cancer and other diseases. Established in 2014, it develops Site-Seeker, a platform that systematically uncovers druggable sites in the human genome and links them to useful therapeutic functions in live cells.
Nu Quantum
Seed Round in 2023
Nu Quantum Ltd is a company focused on developing quantum photonics hardware and quantum networking infrastructure to enhance the capabilities of quantum computing. Established in 2018 and based in Cambridge, United Kingdom, the company specializes in creating photon sources, detectors, and systems for quantum cryptography. Nu Quantum's innovations include nano-engineered materials for the generation of light at the quantum level and ultra-sensitive light detection systems. The company aims to establish the necessary infrastructure for interconnecting quantum computing cores into large distributed clusters, which is essential for scaling quantum computers. By developing full hardware solutions, including high-speed network interfaces and photonic switching fabrics, Nu Quantum seeks to facilitate the creation of entangled qubit networks. The company collaborates with leading quantum computing firms, governments, and research institutions to bring its advanced technologies to market, focusing on secure cryptographic key exchange and the future of information processing.
Phasecraft
Series A in 2023
Phasecraft is a UK-based company founded in 2018 by world-class quantum scientists and engineers. They specialize in developing quantum software for intermediate-scale devices and quantum computers, aiming to accelerate practical applications of quantum computing.
RoboK develops innovative computer vision technology to enhance safety and efficiency in industrial workplaces. Founded in 2017, the company transforms on-site visual data from CCTV cameras into valuable actionable insights for critical infrastructure operators.
DefiniGEN Limited
Series A in 2023
DefiniGEN specializes in providing human cell products for life science and drug discovery sectors. Its offerings include specialized hepatocytes and pancreatic cells for predictive toxicology, diabetes research, and disease modeling. The company serves pharmaceutical companies by offering custom cell production services and contract services such as Def-PANC diabetes compound profiling.
Founded in 2018, Xampla develops plant-based materials derived from pea protein to replace microplastics. Its product range includes microcapsules for homecare and personal care products, films, coatings, and single-use plastics for packaging applications.
AccelerComm
Series B in 2023
AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.
LettUs Grow
Series A in 2023
LettUs Grow Ltd. is a company based in Bristol, United Kingdom, founded in 2015, that specializes in aeroponic irrigation and control technology for indoor farming. The company develops innovative systems that enable plants to grow without soil, using a fine mist for watering and LED lighting for photosynthesis. Their modular, nozzle-free aeroponic hardware is designed to be easy to clean and fully automatable, which reduces the reliance on pesticides and minimizes operational costs. In addition to hardware, LettUs Grow provides software and data services that optimize farming practices, enhancing efficiency and sustainability while lowering the environmental impact of agriculture. The company is committed to transforming farming through technology, aiming to create a more sustainable and efficient agricultural industry.
Mind Foundry
Series B in 2023
Mind Foundry Limited, incorporated in 2015 and based in Oxford, United Kingdom, develops enterprise software that enables organizations to extract valuable insights from their data. As an Oxford University company founded by leading experts in artificial intelligence and machine learning, Mind Foundry focuses on creating Responsible AI solutions designed to address significant real-world challenges across various sectors, including insurance, infrastructure, and defense. Their AI platform leverages advanced machine learning and algorithmic modeling techniques to help organizations tackle issues such as insurance fraud detection and complex signal processing. By promoting the responsible and transparent use of AI, Mind Foundry aims to foster collaboration between humans and artificial intelligence to address pressing global problems.
Symetrica
Series B in 2023
Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.
Founded in 2016, Qkine is a biotechnology company based in Cambridge, UK. It specializes in manufacturing high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell culture, organoid research, and regenerative medicine.
DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.
Crypto Quantique
Series A in 2022
Crypto Quantique develops quantum-driven security solutions for connected devices by designing a secure chip on silicon that uses quantum processes to generate cryptographic keys. The chip can be integrated into new devices or retrofitted into existing ones, enabling multiple applications to operate with unique, unforgeable keys that do not need to be stored. The company combines cryptography and quantum physics in a platform that delivers hardware and software products for future-proof cybersecurity, with a focus on protecting local networks and IoT environments through end-to-end security in a scalable manner. Founded in 2015 and based in London, Crypto Quantique aims to provide robust protection for the Internet of Things by enabling on-demand cryptographic operations and key management.
MoA Technology
Series B in 2022
MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.
Concr is a techbio company focused on enhancing cancer treatment through innovative predictive modeling. Utilizing methods derived from astrophysics, Concr aims to accurately forecast patient outcomes and responses to both novel and existing cancer therapies. The company's cloud-native platform, FarrSight®, enables researchers to simulate clinical trials, predict therapeutic responses, and conduct bioinformatics analyses, facilitating a more personalized approach to cancer care. By leveraging fragmented data from various stages of drug development, Concr eliminates the reliance on big data while generating precise multi-modal tumor models. Headquartered in London, with a subsidiary in Brisbane, Australia, Concr is backed by prominent investors, including the University of Cambridge Enterprise and Oncology Ventures, among others.
Ceryx Medical
Seed Round in 2022
Ceryx Medical Limited is a biotechnology company based in Bath, United Kingdom, founded in 2016. The company specializes in developing and manufacturing innovative bio-electronic devices that utilize unique, patent-protected chip technology. These devices are designed to mimic Central Pattern Generators (CPGs), which are nerve centers in the body responsible for regulating various autonomic and rhythmical processes, including peristalsis, heart rate, and walking. Ceryx Medical aims to restore normal physiological functions that may be compromised due to disease or injury by employing artificial CPGs in their therapeutic devices.
GripAble Ltd. is a London-based company founded in 2017 that specializes in the development of digital therapy devices aimed at improving rehabilitation for individuals with movement impairments. The company’s flagship product, the GripAble Digital Handgrip, is a sensitive, portable device that wirelessly connects to a mobile application. This app allows users to engage in interactive therapy games designed to facilitate the assessment and training of hand and arm functions. GripAble's solutions target patients suffering from conditions such as stroke, arthritis, cerebral palsy, and trauma, addressing the challenges faced by over 500 million people globally who experience impaired arm mobility. By combining hardware with gamified therapy, GripAble enhances patient engagement and enables effective self-training both in clinical settings and at home.
Sano Genetics
Series A in 2022
Sano Genetics is a health technology company that operates a user-centered genetic data-sharing platform. The platform enables researchers to analyze data provided with user consent and to recruit for studies and clinical trials based on participants’ genetic and health information. It provides access to research on genetics and genetic diseases and supports programs that study the genetics of various human traits. The company connects individuals with researchers through its platform, supporting both common and rare disease research and enabling dynamic, health and genetic data sets to advance personalized medicine. Founded in 2017 and based in Cambridge, United Kingdom, Sano Genetics aims to empower participants to contribute their genetic and health data to scientific studies, facilitating collaboration and enabling new approaches to diagnosis and treatment.
BibliU Ltd is a software platform developed to provide online access to textbooks and educational materials, catering primarily to colleges and universities. Founded in 2014 and headquartered in London, with an additional office in New York, BibliU offers a comprehensive digital content management solution that allows students to access textbooks and supplementary courseware from various devices anytime and anywhere. The platform boasts partnerships with thousands of publishers and open educational resource providers, making millions of digital resources available. Key features include instant access to course content, a discovery search tool, offline support, and analytics, along with synchronized highlights and comments to enhance the learning experience. Overall, BibliU aims to blend academic accessibility with affordability and automation in education.
Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.
Bramble Energy
Series B in 2022
Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.
Orthox Ltd. is a medical implant company based in Abingdon, United Kingdom, that specializes in developing tissue regenerative implants for knee cartilage injuries. Founded to commercialize technology from Oxford University, Orthox aims to transform the treatment of cartilage damage, addressing the needs of over 300 million patients worldwide affected by osteoarthritis. The company's flagship product, FibroFix, is a hydrogel implant designed to emulate human knee cartilage, enabling effective repair and regeneration of damaged tissues. Orthox offers several variations of FibroFix, including FibroFix Meniscus for meniscal cartilage repair and FibroFix Cartilage for articular cartilage damage. The implants promote integration with the body's cells, facilitating a return to active, pain-free living. With plans to expand its technology to other joints and additional applications beyond orthopaedics, Orthox is positioned to capitalize on the rapidly growing biomaterials market, projected to exceed $250 billion by 2025.
Sano Genetics
Seed Round in 2022
Sano Genetics is a health technology company that operates a user-centered genetic data-sharing platform. The platform enables researchers to analyze data provided with user consent and to recruit for studies and clinical trials based on participants’ genetic and health information. It provides access to research on genetics and genetic diseases and supports programs that study the genetics of various human traits. The company connects individuals with researchers through its platform, supporting both common and rare disease research and enabling dynamic, health and genetic data sets to advance personalized medicine. Founded in 2017 and based in Cambridge, United Kingdom, Sano Genetics aims to empower participants to contribute their genetic and health data to scientific studies, facilitating collaboration and enabling new approaches to diagnosis and treatment.
Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.
DiffBlue
Seed Round in 2022
DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.
Brainomix
Series B in 2021
Brainomix develops AI-powered imaging biomarkers for neurological and cerebrovascular disorders. Its software suite, including e-ASPECTS, e-CTA, and e-Mismatch, automates brain scan analysis to assist physicians in making timely treatment decisions for stroke patients.
PetMedix Ltd is a veterinary biopharmaceutical company based in Hinxton, United Kingdom, that specializes in therapeutic drug discovery for pets. Founded in 2017, the company utilizes advanced scientific techniques to develop innovative antibody therapies aimed at improving the health and well-being of companion animals. PetMedix has created specialized platforms, including the Ky9 and Felyne transgenic mouse systems, which are designed to produce therapeutic-quality antibodies tailored for pets. This approach allows for the generation of a diverse repertoire of antibodies that mirrors the immune systems of companion animals, enabling veterinarians to administer safe and effective monoclonal antibody treatments. By applying over thirty years of expertise in human drug development to veterinary medicine, PetMedix is dedicated to enhancing the quality of life for pets through cutting-edge therapies.
Nyobolt
Venture Round in 2021
Founded in 2020, Nyobolt is a UK-based company specializing in advanced battery technology for automotive applications. It focuses on developing high-power, fast-charging batteries with large energy storage capacity.
Echion Technologies
Series A in 2021
Echion Technologies, founded in 2017 and based in Cambridge, United Kingdom, specializes in developing advanced anode materials for lithium-ion (Li-ion) batteries. Their proprietary XNO® material offers faster charging times, longer lifespans, and improved safety compared to traditional options. The company targets the heavy-duty electric vehicle market, aiming to enhance efficiency and sustainability within the transportation sector by providing optimized power anode materials for cost-effective battery production.
Bonnet Ltd. is a London-based company established in 2019 that specializes in charging-as-a-service solutions for electric vehicle drivers. Its platform simplifies the charging experience by enabling users to access a wide network of public chargers through a single application, eliminating the need for separate registrations with individual charging networks. By streamlining the process, Bonnet aims to enhance convenience for both drivers and businesses, facilitating easier and more efficient electric vehicle charging.
PredictImmune
Series A in 2021
PredictImmune Ltd is a biotechnology company based in Cambridge, United Kingdom, focused on developing prognostic tests for immune-mediated inflammatory diseases. Established in 2017, the company offers PredictSURE IBD, a diagnostic tool designed to identify patients with Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, who are at risk of severe, relapsing disease. This simple lab test requires only a small blood sample and provides critical insights that enable healthcare providers to tailor early biologic therapies for at-risk patients. By delivering personalized treatment options, PredictImmune aims to improve disease management and clinical outcomes for individuals suffering from IBD, addressing an important need recognized by physicians, patients, and payors alike.
GripAble
Seed Round in 2021
GripAble Ltd. is a London-based company founded in 2017 that specializes in the development of digital therapy devices aimed at improving rehabilitation for individuals with movement impairments. The company’s flagship product, the GripAble Digital Handgrip, is a sensitive, portable device that wirelessly connects to a mobile application. This app allows users to engage in interactive therapy games designed to facilitate the assessment and training of hand and arm functions. GripAble's solutions target patients suffering from conditions such as stroke, arthritis, cerebral palsy, and trauma, addressing the challenges faced by over 500 million people globally who experience impaired arm mobility. By combining hardware with gamified therapy, GripAble enhances patient engagement and enables effective self-training both in clinical settings and at home.
PhoreMost
Series B in 2021
PhoreMost is a UK-based drug discovery company specializing in identifying new druggable targets for cancer and other diseases. Established in 2014, it develops Site-Seeker, a platform that systematically uncovers druggable sites in the human genome and links them to useful therapeutic functions in live cells.
Mirriad Advertising
Post in 2020
Mirriad Advertising, established in 2015 and headquartered in London, specializes in in-video advertising solutions. It uses artificial intelligence and computer vision technology to dynamically insert products and signage into existing video content, creating new advertising inventory for content producers and distributors. This approach enhances viewer engagement and limits commercial interruptions. Mirriad serves clients in the UK, US, China, and other countries, generating the majority of its revenue in the US.
Phasecraft
Seed Round in 2020
Phasecraft is a UK-based company founded in 2018 by world-class quantum scientists and engineers. They specialize in developing quantum software for intermediate-scale devices and quantum computers, aiming to accelerate practical applications of quantum computing.
1715Labs
Seed Round in 2020
1715 Labs Ltd specializes in data labeling services powered by artificial intelligence. Founded in 2018 and located in Oxford, United Kingdom, the company offers a range of solutions in computer vision and language processing. Its computer vision capabilities include image categorization and various forms of segmentation, while its language processing services encompass text classification, relationship identification, and sentiment recognition, among others. By combining human expertise with advanced statistical tools, 1715 Labs aims to provide organizations with rapid and cost-effective data training, labeling, and analysis, ultimately assisting businesses in effectively utilizing their data. Additionally, 1715 Labs is focused on commercializing Zooniverse technology to expand its offerings in the data labeling market.
MoA Technology
Series A in 2020
MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.
Nyobolt
Seed Round in 2020
Founded in 2020, Nyobolt is a UK-based company specializing in advanced battery technology for automotive applications. It focuses on developing high-power, fast-charging batteries with large energy storage capacity.
Ceryx Medical
Seed Round in 2020
Ceryx Medical Limited is a biotechnology company based in Bath, United Kingdom, founded in 2016. The company specializes in developing and manufacturing innovative bio-electronic devices that utilize unique, patent-protected chip technology. These devices are designed to mimic Central Pattern Generators (CPGs), which are nerve centers in the body responsible for regulating various autonomic and rhythmical processes, including peristalsis, heart rate, and walking. Ceryx Medical aims to restore normal physiological functions that may be compromised due to disease or injury by employing artificial CPGs in their therapeutic devices.
Nu Quantum
Seed Round in 2020
Nu Quantum Ltd is a company focused on developing quantum photonics hardware and quantum networking infrastructure to enhance the capabilities of quantum computing. Established in 2018 and based in Cambridge, United Kingdom, the company specializes in creating photon sources, detectors, and systems for quantum cryptography. Nu Quantum's innovations include nano-engineered materials for the generation of light at the quantum level and ultra-sensitive light detection systems. The company aims to establish the necessary infrastructure for interconnecting quantum computing cores into large distributed clusters, which is essential for scaling quantum computers. By developing full hardware solutions, including high-speed network interfaces and photonic switching fabrics, Nu Quantum seeks to facilitate the creation of entangled qubit networks. The company collaborates with leading quantum computing firms, governments, and research institutions to bring its advanced technologies to market, focusing on secure cryptographic key exchange and the future of information processing.
GaitQ Limited is a medical device company founded in 2019 and based in Oxfordshire, United Kingdom. It specializes in developing the GaitThaw device, which addresses the issue of gait freezing in individuals with Parkinson's disease. This small and portable device employs clinically proven sensory cues to assist patients in re-establishing the connection between the brain and body, thereby facilitating smoother walking. GaitQ aims to improve mobility and enhance the quality of life for those affected by this debilitating symptom of Parkinson's disease.
Bramble Energy
Series A in 2020
Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.
Symetrica
Venture Round in 2020
Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.
Bramble Energy
Seed Round in 2020
Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.
Ceryx Medical
Seed Round in 2020
Ceryx Medical Limited is a biotechnology company based in Bath, United Kingdom, founded in 2016. The company specializes in developing and manufacturing innovative bio-electronic devices that utilize unique, patent-protected chip technology. These devices are designed to mimic Central Pattern Generators (CPGs), which are nerve centers in the body responsible for regulating various autonomic and rhythmical processes, including peristalsis, heart rate, and walking. Ceryx Medical aims to restore normal physiological functions that may be compromised due to disease or injury by employing artificial CPGs in their therapeutic devices.
Mind Foundry
Series A in 2020
Mind Foundry Limited, incorporated in 2015 and based in Oxford, United Kingdom, develops enterprise software that enables organizations to extract valuable insights from their data. As an Oxford University company founded by leading experts in artificial intelligence and machine learning, Mind Foundry focuses on creating Responsible AI solutions designed to address significant real-world challenges across various sectors, including insurance, infrastructure, and defense. Their AI platform leverages advanced machine learning and algorithmic modeling techniques to help organizations tackle issues such as insurance fraud detection and complex signal processing. By promoting the responsible and transparent use of AI, Mind Foundry aims to foster collaboration between humans and artificial intelligence to address pressing global problems.
Symetrica
Venture Round in 2020
Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.
Founded in 2016, Qkine is a biotechnology company based in Cambridge, UK. It specializes in manufacturing high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell culture, organoid research, and regenerative medicine.
Flusso Ltd, established in 2016 and headquartered in Cambridge, United Kingdom, specializes in the development and manufacturing of sensor solutions tailored to various industries. The company produces mass flow and air velocity sensors, leveraging proprietary technology to meet specific application needs.
Oxford Flow
Venture Round in 2020
Oxford Flow designs, manufactures, and supplies pressure control equipment, including gas and fluid pressure regulators, water PRVs, silencers, and pilots, serving water, gas, marine, oil and gas, process, power, building services, and specialty applications. The company develops small, light, and reliable conventional valves that simplify systems and ensure continual potable water supplies while meeting standards for water quality and leakage control. It combines academic and industry expertise to develop practical, rigorously tested solutions that perform under harsh conditions, aiming to reduce total cost of ownership and environmental impact while improving reliability and energy efficiency. Based in Oxford, United Kingdom.
Sorex Sensors
Series A in 2020
Sorex Sensors designs and manufactures high-sensitivity micro-electro-mechanical system (MEMS) mass sensors based on film bulk acoustic resonator (FBAR) technology. Their products, fabricated on silicon wafers, measure mass down to the femtogram range and temperature with a resolution of 0.2°C, making them suitable for thin film metrology, particulate monitoring, and gas detection applications.
Founded in 2018, Xampla develops plant-based materials derived from pea protein to replace microplastics. Its product range includes microcapsules for homecare and personal care products, films, coatings, and single-use plastics for packaging applications.
Ilika specializes in accelerating material development for energy and electronics applications using proprietary high-throughput techniques. Its solid-state battery technology powers miniature medical devices, industrial IoT, electric vehicles, and consumer electronics across Asia, Europe, North America, and the UK.
Echion Technologies
Series A in 2020
Echion Technologies, founded in 2017 and based in Cambridge, United Kingdom, specializes in developing advanced anode materials for lithium-ion (Li-ion) batteries. Their proprietary XNO® material offers faster charging times, longer lifespans, and improved safety compared to traditional options. The company targets the heavy-duty electric vehicle market, aiming to enhance efficiency and sustainability within the transportation sector by providing optimized power anode materials for cost-effective battery production.
RoboK develops innovative computer vision technology to enhance safety and efficiency in industrial workplaces. Founded in 2017, the company transforms on-site visual data from CCTV cameras into valuable actionable insights for critical infrastructure operators.
Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.
LettUs Grow
Seed Round in 2019
LettUs Grow Ltd. is a company based in Bristol, United Kingdom, founded in 2015, that specializes in aeroponic irrigation and control technology for indoor farming. The company develops innovative systems that enable plants to grow without soil, using a fine mist for watering and LED lighting for photosynthesis. Their modular, nozzle-free aeroponic hardware is designed to be easy to clean and fully automatable, which reduces the reliance on pesticides and minimizes operational costs. In addition to hardware, LettUs Grow provides software and data services that optimize farming practices, enhancing efficiency and sustainability while lowering the environmental impact of agriculture. The company is committed to transforming farming through technology, aiming to create a more sustainable and efficient agricultural industry.
Covatic develops broadcast personalization software and a consumer insights platform that enables on-device personalization for applications. Incorporated in 2016, the company is based in Birmingham, United Kingdom, with an additional office in London. Its platform provides an on-device software development kit that leverages trusted first-party and offline consented data to create contextual audience segments, helping media companies deliver relevant advertising while strengthening user trust and complying with privacy regulations.
Undo
Venture Round in 2019
Undo Ltd., established in 2005, specializes in developing debugging tools for software developers. Its flagship product, LiveRecorder, records and replays software execution to aid in identifying and fixing programming errors. UndoDB, another key offering, provides an interactive reversible debugger for C/C++ on Linux and Android platforms. The company serves industries such as data management, networking, electronic design automation, and finance, with offices in Cambridge, UK, and San Francisco, CA.
MoA Technology
Series A in 2019
MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.
Mirriad Advertising
Post in 2019
Mirriad Advertising, established in 2015 and headquartered in London, specializes in in-video advertising solutions. It uses artificial intelligence and computer vision technology to dynamically insert products and signage into existing video content, creating new advertising inventory for content producers and distributors. This approach enhances viewer engagement and limits commercial interruptions. Mirriad serves clients in the UK, US, China, and other countries, generating the majority of its revenue in the US.
PredictImmune
Series B in 2019
PredictImmune Ltd is a biotechnology company based in Cambridge, United Kingdom, focused on developing prognostic tests for immune-mediated inflammatory diseases. Established in 2017, the company offers PredictSURE IBD, a diagnostic tool designed to identify patients with Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, who are at risk of severe, relapsing disease. This simple lab test requires only a small blood sample and provides critical insights that enable healthcare providers to tailor early biologic therapies for at-risk patients. By delivering personalized treatment options, PredictImmune aims to improve disease management and clinical outcomes for individuals suffering from IBD, addressing an important need recognized by physicians, patients, and payors alike.
Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.
Symetrica
Venture Round in 2019
Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.
Founded in 2016, Qkine is a biotechnology company based in Cambridge, UK. It specializes in manufacturing high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell culture, organoid research, and regenerative medicine.
Inductosense
Series A in 2019
Inductosense Ltd is a manufacturer based in Bristol, United Kingdom, specializing in wireless and battery-free sensors designed for the detection of cracks, corrosion, and defects in various structures and products. Founded in 2015, the company offers innovative solutions such as the WAND Evaluation System, which includes a set of sensors, a handheld measurement probe, and a sensor fixing kit for measuring structural thickness. Additionally, Inductosense develops TRND systems for monitoring internal corrosion and erosion in pipework and vessels. The sensors can be permanently affixed to surfaces and are capable of operating beneath coatings, insulation, or repairs. They utilize a passive technology that relies on non-contact inductive coupling to receive power and transmit signals, allowing for fast and repeatable inspections. Inductosense's products are applicable in the inspection of large structures, composite repairs, and remote monitoring, providing clients with reliable data for maintenance and safety assessments.
PolyProx
Seed Round in 2019
PolyProx Therapeutics Ltd is a biotechnology company based in Cambridge, United Kingdom, founded in 2018. It focuses on researching and developing innovative drug therapies aimed at treating cancer and neurodegenerative diseases. The company's flagship product, Polyproxin, utilizes engineered proteins that selectively target tumor cells. This mechanism activates the natural degradation processes within the cells, allowing for the removal of disease-causing proteins. By employing this novel approach, PolyProx aims to provide effective treatment options for cancer patients, potentially improving their outcomes and quality of life.
Cytora provides a configurable risk digitization and analytics platform for commercial insurance. The platform digitizes each incoming risk, augments it with internal and external data sources, and evaluates it against rules governing appetite and priority before routing to downstream underwriting systems for automated or manual processing. Using artificial intelligence, Cytora learns patterns of risk and loss outcomes over time, computes a risk rank, score, and price for each property and organization, and helps insurers target profitable risks, improve risk selection, and optimize pricing. The company was founded in 2014 and is headquartered in London.
Perpetuum
Venture Round in 2019
Perpetuum Ltd. is a company based in Southampton, United Kingdom, that specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 as a technology spin-off from the University of Southampton, Perpetuum has developed innovative self-powered wireless sensor solutions designed for condition monitoring in various industries, including rail, oil and gas, chemicals, and power generation. Its flagship products convert mechanical vibration into electrical energy, allowing for the operation of autonomous, maintenance-free wireless sensor nodes that transmit critical data on equipment health and performance. Perpetuum is recognized as the global leader in vibration energy harvesting, continually advancing the practical applications of this technology to enhance operational efficiency and safety in industrial environments.
Founded in 2012, Aqdot specializes in innovative microencapsulation technology. Its patented one-step shrink-wrap approach combines emulsion technology and supramolecular chemistry to create smart microcapsules with customizable properties. This energy-efficient manufacturing process serves various industries, including household care, agrochemicals, and food sectors.
Phasecraft
Seed Round in 2019
Phasecraft is a UK-based company founded in 2018 by world-class quantum scientists and engineers. They specialize in developing quantum software for intermediate-scale devices and quantum computers, aiming to accelerate practical applications of quantum computing.
Mind Foundry
Seed Round in 2019
Mind Foundry Limited, incorporated in 2015 and based in Oxford, United Kingdom, develops enterprise software that enables organizations to extract valuable insights from their data. As an Oxford University company founded by leading experts in artificial intelligence and machine learning, Mind Foundry focuses on creating Responsible AI solutions designed to address significant real-world challenges across various sectors, including insurance, infrastructure, and defense. Their AI platform leverages advanced machine learning and algorithmic modeling techniques to help organizations tackle issues such as insurance fraud detection and complex signal processing. By promoting the responsible and transparent use of AI, Mind Foundry aims to foster collaboration between humans and artificial intelligence to address pressing global problems.
PetMedix Ltd is a veterinary biopharmaceutical company based in Hinxton, United Kingdom, that specializes in therapeutic drug discovery for pets. Founded in 2017, the company utilizes advanced scientific techniques to develop innovative antibody therapies aimed at improving the health and well-being of companion animals. PetMedix has created specialized platforms, including the Ky9 and Felyne transgenic mouse systems, which are designed to produce therapeutic-quality antibodies tailored for pets. This approach allows for the generation of a diverse repertoire of antibodies that mirrors the immune systems of companion animals, enabling veterinarians to administer safe and effective monoclonal antibody treatments. By applying over thirty years of expertise in human drug development to veterinary medicine, PetMedix is dedicated to enhancing the quality of life for pets through cutting-edge therapies.
Flusso
Venture Round in 2019
Flusso Ltd, established in 2016 and headquartered in Cambridge, United Kingdom, specializes in the development and manufacturing of sensor solutions tailored to various industries. The company produces mass flow and air velocity sensors, leveraging proprietary technology to meet specific application needs.
Echion Technologies
Seed Round in 2018
Echion Technologies, founded in 2017 and based in Cambridge, United Kingdom, specializes in developing advanced anode materials for lithium-ion (Li-ion) batteries. Their proprietary XNO® material offers faster charging times, longer lifespans, and improved safety compared to traditional options. The company targets the heavy-duty electric vehicle market, aiming to enhance efficiency and sustainability within the transportation sector by providing optimized power anode materials for cost-effective battery production.
Bramble Energy
Seed Round in 2018
Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.
Undo Ltd., established in 2005, specializes in developing debugging tools for software developers. Its flagship product, LiveRecorder, records and replays software execution to aid in identifying and fixing programming errors. UndoDB, another key offering, provides an interactive reversible debugger for C/C++ on Linux and Android platforms. The company serves industries such as data management, networking, electronic design automation, and finance, with offices in Cambridge, UK, and San Francisco, CA.
PhoreMost
Series A in 2018
PhoreMost is a UK-based drug discovery company specializing in identifying new druggable targets for cancer and other diseases. Established in 2014, it develops Site-Seeker, a platform that systematically uncovers druggable sites in the human genome and links them to useful therapeutic functions in live cells.
Salunda
Venture Round in 2018
Salunda develops robust contactless sensors for use in harsh environments. Its technology detects position and speed and measures fluid composition, enabling inline water cut and multiphase flow sensing for oil, water, and gas fractions, as well as downhole inspection tools and BHA sensors to detect wear and potential failure. The sensors scan components such as pistons, rotors and seals for wear, and can warn of imminent issues by identifying cracks, eccentric motion, orbiting, axial shift, or vibration. The system includes oilfield tooling, production and test separator level sensing in the presence of bubbles and froth, and handheld testers for detecting biofuel in diesel. The company also supplies sensor probes and electronics that measure fluid levels and monitor froth and entrained gases, with self-compensation for changing fluid characteristics and temperature. OEM components support open-bore water cut and multiphase flow applications, and the technology is suitable for intrinsic safety and offshore environments.
Paragraf
Seed Round in 2018
Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.
Oxford Flow
Venture Round in 2018
Oxford Flow designs, manufactures, and supplies pressure control equipment, including gas and fluid pressure regulators, water PRVs, silencers, and pilots, serving water, gas, marine, oil and gas, process, power, building services, and specialty applications. The company develops small, light, and reliable conventional valves that simplify systems and ensure continual potable water supplies while meeting standards for water quality and leakage control. It combines academic and industry expertise to develop practical, rigorously tested solutions that perform under harsh conditions, aiming to reduce total cost of ownership and environmental impact while improving reliability and energy efficiency. Based in Oxford, United Kingdom.
Brainomix
Venture Round in 2018
Brainomix develops AI-powered imaging biomarkers for neurological and cerebrovascular disorders. Its software suite, including e-ASPECTS, e-CTA, and e-Mismatch, automates brain scan analysis to assist physicians in making timely treatment decisions for stroke patients.
Bodle Technologies
Series A in 2018
Bodle Technologies, established in 2015 and based in Begbroke, UK, specializes in advanced optoelectronic solutions for displays and smart windows. The company's core product is its proprietary SRD® technology, the world's first solid-state reflective display, which offers ultra-high resolution, vivid color, and video capability with zero energy use for static image storage. This bi-stable reflective display is ideal for wearables, near-eye, and projection-based displays, providing a more natural viewing experience, particularly in outdoor conditions. Additionally, Bodle Technologies develops security coatings that change color under various probing techniques, ensuring unbreakable security features in currencies, ID cards, and official documentation.
Cytora provides a configurable risk digitization and analytics platform for commercial insurance. The platform digitizes each incoming risk, augments it with internal and external data sources, and evaluates it against rules governing appetite and priority before routing to downstream underwriting systems for automated or manual processing. Using artificial intelligence, Cytora learns patterns of risk and loss outcomes over time, computes a risk rank, score, and price for each property and organization, and helps insurers target profitable risks, improve risk selection, and optimize pricing. The company was founded in 2014 and is headquartered in London.
MoA Technology
Seed Round in 2017
MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.
Intelligent Ultrasound Group
Venture Round in 2017
Intelligent Ultrasound Group is a company specializing in the development, marketing, and distribution of medical training simulators and clinical ultrasound software. Based in Cardiff, United Kingdom, it offers a range of innovative products designed to enhance the quality and reliability of medical ultrasound. Its clinical AI software products, including ScanNav Audit, ScanNav AutoCapture, and ScanNav AnatomyGuide, provide real-time support and automation in ultrasound procedures, such as fetal anomaly scans and the identification of key anatomical structures. The company's training simulators, such as ScanTrainer for obstetrics and gynecology, HeartWorks for cardiac training, and BodyWorks for emergency medicine, are widely used to educate medical professionals. Intelligent Ultrasound Group, which was founded in 2004 and formerly known as MedaPhor Group, has a significant presence in the United Kingdom, North America, and other international markets.
Mind Foundry
Seed Round in 2017
Mind Foundry Limited, incorporated in 2015 and based in Oxford, United Kingdom, develops enterprise software that enables organizations to extract valuable insights from their data. As an Oxford University company founded by leading experts in artificial intelligence and machine learning, Mind Foundry focuses on creating Responsible AI solutions designed to address significant real-world challenges across various sectors, including insurance, infrastructure, and defense. Their AI platform leverages advanced machine learning and algorithmic modeling techniques to help organizations tackle issues such as insurance fraud detection and complex signal processing. By promoting the responsible and transparent use of AI, Mind Foundry aims to foster collaboration between humans and artificial intelligence to address pressing global problems.
Inductosense
Series A in 2017
Inductosense Ltd is a manufacturer based in Bristol, United Kingdom, specializing in wireless and battery-free sensors designed for the detection of cracks, corrosion, and defects in various structures and products. Founded in 2015, the company offers innovative solutions such as the WAND Evaluation System, which includes a set of sensors, a handheld measurement probe, and a sensor fixing kit for measuring structural thickness. Additionally, Inductosense develops TRND systems for monitoring internal corrosion and erosion in pipework and vessels. The sensors can be permanently affixed to surfaces and are capable of operating beneath coatings, insulation, or repairs. They utilize a passive technology that relies on non-contact inductive coupling to receive power and transmit signals, allowing for fast and repeatable inspections. Inductosense's products are applicable in the inspection of large structures, composite repairs, and remote monitoring, providing clients with reliable data for maintenance and safety assessments.
Zegami Limited is a company that specializes in visual data exploration, offering a platform designed to assist in analyzing both scientific and medical imaging. Founded in 2015 and headquartered in Oxford, United Kingdom, Zegami's solution integrates media, data, and artificial intelligence to transform visual data into actionable information. The platform enables users to efficiently search, sort, filter, and group large collections of images and associated metadata in real time, facilitating the identification of patterns, correlations, and anomalies within the data. Its applications span various fields, including heating, ventilation, and air conditioning management, microscopy, genomics, plant phenotyping, and cultural heritage institutions such as galleries and museums. Additionally, Zegami's plugin API allows developers to create custom visualizations, enhancing the versatility of their offerings.
Creavo Medical Technologies
Series B in 2017
Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Incorporated in 2014, the company has its headquarters in Coventry and additional facilities in Leeds. Creavo specializes in creating portable, battery-powered devices that utilize magnetocardiography to detect heart-related issues, such as acute coronary syndromes and ischemia, directly at the patient's bedside. Founded by a team of clinical, research, and business experts, the company aims to improve diagnostic techniques and enhance patient outcomes in healthcare settings. Creavo Medical Technologies was previously known as Quantum Imaging Limited before rebranding in September 2016.
PredictImmune
Series A in 2017
PredictImmune Ltd is a biotechnology company based in Cambridge, United Kingdom, focused on developing prognostic tests for immune-mediated inflammatory diseases. Established in 2017, the company offers PredictSURE IBD, a diagnostic tool designed to identify patients with Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, who are at risk of severe, relapsing disease. This simple lab test requires only a small blood sample and provides critical insights that enable healthcare providers to tailor early biologic therapies for at-risk patients. By delivering personalized treatment options, PredictImmune aims to improve disease management and clinical outcomes for individuals suffering from IBD, addressing an important need recognized by physicians, patients, and payors alike.
Azul Optics
Series B in 2017
Azul Optics is a medical device company based in Bristol, United Kingdom, founded in 2016, developing a device to rapidly and conveniently assess macular pigment density as an index of eye health. The device is designed to be affordable, fast, easy to use, and compact, enabling eye health professionals to incorporate macular pigment density screening into routine eye exams and support age-related macular degeneration prevention.
NuNano is a UK-based company founded in 2011 that specializes in designing and manufacturing probes for atomic force microscopy (AFM) and cantilever-based sensor devices. Established by Dr. James Vicary and Professors Heinrich Hoerber and Mervyn Miles, NuNano aims to innovate the AFM industry, which had seen little change over two decades, by introducing new manufacturing methods and providing superior customer service. The company's proprietary microfabrication processes allow it to produce AFM probes with the tightest dimensional tolerances available, facilitating precise investigations of nano-scale material properties. These probes are utilized across various applications, including routine quality control in the semiconductor industry and research in molecular biology. NuNano is committed to ensuring an optimal experience for AFM users, from initial website interaction to post-experiment probe storage.
BibliU Ltd is a software platform developed to provide online access to textbooks and educational materials, catering primarily to colleges and universities. Founded in 2014 and headquartered in London, with an additional office in New York, BibliU offers a comprehensive digital content management solution that allows students to access textbooks and supplementary courseware from various devices anytime and anywhere. The platform boasts partnerships with thousands of publishers and open educational resource providers, making millions of digital resources available. Key features include instant access to course content, a discovery search tool, offline support, and analytics, along with synchronized highlights and comments to enhance the learning experience. Overall, BibliU aims to blend academic accessibility with affordability and automation in education.
Covatic develops broadcast personalization software and a consumer insights platform that enables on-device personalization for applications. Incorporated in 2016, the company is based in Birmingham, United Kingdom, with an additional office in London. Its platform provides an on-device software development kit that leverages trusted first-party and offline consented data to create contextual audience segments, helping media companies deliver relevant advertising while strengthening user trust and complying with privacy regulations.
Cytora provides a configurable risk digitization and analytics platform for commercial insurance. The platform digitizes each incoming risk, augments it with internal and external data sources, and evaluates it against rules governing appetite and priority before routing to downstream underwriting systems for automated or manual processing. Using artificial intelligence, Cytora learns patterns of risk and loss outcomes over time, computes a risk rank, score, and price for each property and organization, and helps insurers target profitable risks, improve risk selection, and optimize pricing. The company was founded in 2014 and is headquartered in London.
Polypharmakos
Series A in 2017
Founded in 2016, Polypharmakos is a UK-based company dedicated to discovering and developing new antimicrobials from plants, fungi, and other natural product sources. Its mission is to address the global crisis of antimicrobial resistance.
Exonate
Angel Round in 2016
Exonate is a biotechnology company focused on developing small molecule drugs that modulate alternative messenger RNA splicing. It specializes in ophthalmology, with a primary focus on treating diabetic retinopathy and diabetic macular oedema (DMO), as well as wet age-related macular degeneration (wAMD). The company's lead program aims to provide superior efficacy through topical agents in preclinical models of wAMD.